A
Anat Mirelman
Researcher at Tel Aviv Sourasky Medical Center
Publications - 246
Citations - 12440
Anat Mirelman is an academic researcher from Tel Aviv Sourasky Medical Center. The author has contributed to research in topics: Medicine & Gait (human). The author has an hindex of 47, co-authored 208 publications receiving 9246 citations. Previous affiliations of Anat Mirelman include Harvard University & Ben-Gurion University of the Negev.
Papers
More filters
Journal ArticleDOI
Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.
Roy N. Alcalay,Anat Mirelman,Rachel Saunders-Pullman,Ming X. Tang,Helen Mejia Santana,Deborah Raymond,Ernest Roos,Martha Orbe-Reilly,Tanya Gurevich,Anat Bar Shira,Mali Gana Weisz,Kira Yasinovsky,Maayan Zalis,Avner Thaler,Andres Deik,Matthew J. Barrett,Jose Cabassa,Mark Groves,Ann L. Hunt,Naomi Lubarr,Marta San Luciano,Joan Miravite,Christina Palmese,Rivka Sachdev,Harini Sarva,Lawrence Severt,Vicki Shanker,Matthew Swan,Jeannie Soto-Valencia,Brooke Johannes,Roberto A. Ortega,Stanley Fahn,Lucien J. Cote,Cheryl Waters,Pietro Mazzoni,Blair Ford,Elan D. Louis,Oren A. Levy,Llency Rosado,Diana Ruiz,Tsvyatko Dorovski,Michael W. Pauciulo,William C. Nichols,Avi Orr-Urtreger,Avi Orr-Urtreger,Laurie J. Ozelius,Lorraine N. Clark,Nir Giladi,Susan Bressman,Karen Marder +49 more
TL;DR: PD in AJ LRRK2 G2019S mutation carriers is similar to idiopathic PD but is characterized by more frequent lower extremity involvement at onset and PIGD without the associated cognitive impairment.
Journal ArticleDOI
Is every-day walking in older adults more analogous to dual-task walking or to usual walking? Elucidating the gaps between gait performance in the lab and during 24/7 monitoring.
Inbar Hillel,Eran Gazit,Alice Nieuwboer,Laura Avanzino,Lynn Rochester,Lynn Rochester,Andrea Cereatti,Ugo Della Croce,Marcel G. M. Olde Rikkert,Bastiaan R. Bloem,Elisa Pelosin,Silvia Del Din,Pieter Ginis,Nir Giladi,Nir Giladi,Anat Mirelman,Anat Mirelman,Jeffrey M. Hausdorff +17 more
TL;DR: Gait values measured during relatively long (30-s) daily-living walking bouts are more similar to the corresponding values obtained in the lab during dual-task walking, as compared to usual walking.
Journal ArticleDOI
Virtual reality and motor imagery: promising tools for assessment and therapy in Parkinson's disease.
TL;DR: Encouraging findings on the potential benefits of using MI and VR in PD were found, although further good‐quality research is still needed, and questions remain on the optimal use, content of interventions, and generalizability of findings across the different stages of the disease.
Journal ArticleDOI
Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry.
Annie J. Lee,Yuanjia Wang,Roy N. Alcalay,Helen Mejia-Santana,Rachel Saunders-Pullman,Susan B. Bressman,Jean-Christophe Corvol,Alexis Brice,Suzanne Lesage,Graziella Mangone,Eduardo Tolosa,Claustre Pont-Sunyer,Dolores Vilas,Birgitt Schüle,Farah Kausar,Tatiana Foroud,Daniela Berg,Kathrin Brockmann,Stefano Goldwurm,Chiara Siri,Rosanna Asselta,Javier Ruiz-Martínez,Elisabet Mondragon,Connie Marras,Taneera Ghate,Nir Giladi,Anat Mirelman,Karen Marder +27 more
TL;DR: Penetrance estimates of the leucine‐rich repeat kinase 2 (LRRK2) p.G2019S mutation for PD vary widely (24%‐100%) and it is unknown whether penetrance varies among different ethnic groups.
Journal ArticleDOI
Analysis of Free-Living Gait in Older Adults With and Without Parkinson's Disease and With and Without a History of Falls: Identifying Generic and Disease-Specific Characteristics.
Silvia Del Din,Brook Galna,Alan Godfrey,Alan Godfrey,Esther M.J. Bekkers,Elisa Pelosin,Freek Nieuwhof,Anat Mirelman,Jeffrey M. Hausdorff,Jeffrey M. Hausdorff,Jeffrey M. Hausdorff,Lynn Rochester,Lynn Rochester +12 more
TL;DR: Common and disease-specific changes in free-living Macro and Micro gait highlight generic and selective targets for intervention depending on type of faller (OA-PD).